TCR γ4δ1-Engineered αβT Cells Exhibit Effective Antitumor Activity
Abstract T cell engineering with T cell receptors (TCRs) specific for tumors plays an important role in adoptive T cell transfer (ATC) therapy for cancer. Here, we present a novel strategy to redirect peripheral blood-derived αβT cells against tumors via TCRγ4δ1 gene transduction. The broad-spectrum...
Saved in:
Main Authors: | Kangxia He (Author), Hongqin You (Author), Yuxia Li (Author), Lianxian Cui (Author), Jianmin Zhang (Author), Wei He (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4+CD8+ thymocytes
by: Tianlai Wang, et al.
Published: (2024) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023) -
TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022) -
Dengue virus infection induces selective expansion of Vγ4 and Vγ6TCR γδ T cells in the small intestine and a cytokine storm driving vascular leakage in mice.
by: Takeshi Kurosu, et al.
Published: (2023) -
The significance of αβ Т cells in the development of metainflammation of the adipose tissue in obesity
by: A.E. Abaturov, et al.
Published: (2021)